DE CESARIS, FRANCESCO
DE CESARIS, FRANCESCO
AREA CRITICA MEDICO CHIRURGICA (attivo dal 01/01/2000 al 31/12/2012)
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury
2017 Muzzi, Mirko; Buonvicino, Daniela; De Cesaris, Francesco; Chiarugi, Alberto
Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss
2025 Pistolesi, Alessandra; Tuniz, Simone; Luceri, Cristina; Molli, Alice; Urru, Matteo; La Rocca, Antonino Iurato; Tanturli, Michele; De Cesaris, Francesco; Buonvicino, Daniela; Chiarugi, Alberto
Chronic headaches and medication overuse
2010 Geppetti P.; De Cesaris F.; Nicoletti P.; Benemei S.
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report
2021 Iannone L.F.; Geppetti P.; Chiarugi A.; De Cesaris F.
Criterion-related validity in a sample of migraine outpatients: The diagnostic criteria for psychosomatic research
2020 Cosci F.; Svicher A.; Romanazzo S.; Maggini L.; De Cesaris F.; Benemei S.; Geppetti P.
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
2022 Iannone, Luigi Francesco; De Cesaris, Francesco; Ferrari, Anita; Benemei, Silvia; Fattori, Davide; Chiarugi, Alberto
Emerging Pharmacological Treatments for Migraine in the Pediatric Population
2022 Iannone L.F.; De Cesaris F.; Geppetti P.
Epidemiology and determinants of chronic migraine: A real-world cohort study, with nested case-control analysis, in primary care in Italy
2019 Marconi E.; Pecchioli S.; Nica M.; Colombo D.; Mazzoleni F.; De Cesaris F.; Geppetti P.; Cricelli C.; Lapi F.
Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series
2022 Iannone L.F.; Fattori D.; Geppetti P.; De Cesaris F.
Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)
2020 Delussi M.; Gentile E.; Coppola G.; Prudenzano A.M.P.; Rainero I.; Sances G.; Abagnale C.; Caponnetto V.; De Cesaris F.; Frattale I.; Guaschino E.; Marcinno A.; Ornello R.; Pistoia F.; Putorti A.; Roca M.E.; Roveta F.; Lupi C.; Trojano M.; Pierelli F.; Geppetti P.; Sacco S.; de Tommaso M.
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
2022 Iannone L.F.; Fattori D.; Benemei S.; Chiarugi A.; Geppetti P.; De Cesaris F.
Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study
2020 Benemei S.; Lupi C.; De Cesaris F.; Lombardi N.; Bettiol A.; Chiarugi A.; Geppetti P.; Galli V.; Pracucci C.; Occupati B.; Mannaioni G.
Mental pain and pain-proneness in migraine subjects: Results from the PAINMIG cohort-study
2021 Cosci F.; Svicher A.; Mansueto G.; Benemei S.; Chiarugi A.; De Cesaris F.; Guidi J.; Zipfel S.
Mental pain as a global person-centred outcome measure
2021 Cosci F.; Mansueto G.; Benemei S.; Chiarugi A.; De Cesaris F.; Sensky T.
Mental Pain Questionnaire: An item response theory analysis
2019 Svicher, A.; Romanazzo, S.; De Cesaris, F.; Benemei, S.; Geppetti, P.; Cosci, F.
Mental Pain Questionnaire: Clinimetric Properties of a Potential Global Person‐Centred Outcome Measure
2024 Cosci Fiammetta; Carrozzino Danilo; Patierno Chiara; Romanazzo Sara; Berrocal Carmen; Chiarugi Alberto; De Cesaris Francesco; Guiducci Serena; Mansueto Giovanni; Christensen KajSparle; Sensky Tom
Migraine during covid-19: Data from second wave pandemic in an Italian cohort
2021 Gentile E.; Delussi M.; Abagnale C.; Caponnetto V.; De Cesaris F.; Frattale I.; Guaschino E.; Marcinno A.; Ornello R.; Pistoia F.; Putorti A.; Candida G.; Roveta F.; Lupi C.; Coppola G.; Prudenzano A.M.P.; Rainero I.; Sances G.; Roca M.E.; Trojano M.; Pierelli F.; Geppetti P.; Sacco S.; de Tommaso M.
Migraine Models
2009 S. Benemei; F. De Cesaris; P. Nicoletti; S. Materazzi; R. Nassini; P. Geppetti.
Migraine-provoking substances evoke periorbital allodynia in mice
2019 De Logu F.; Landini L.; Janal M.N.; Li Puma S.; De Cesaris F.; Geppetti P.; Nassini R.
Multi-domain destructuring in the early phases of psychosis: a multicentric phenomenological and psychometric case-control study
2025 Baccaredda Boy O, Merola GP, Patti A, Bozza B, Flaccomio D, Faldi M, Pitt G, Papini L, Pecoraro V, Noschese I, Di Matteo E, Brugnolo D, Ricci C, Ballerini A, Mauceri F, Tavano S, Peroni G, Ciabattini S, Gori S, Pisano T, De Cesaris F, Cohen D, Ricca V
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury | 2017 | Muzzi, Mirko; Buonvicino, Daniela; De Cesaris, Francesco; Chiarugi, Alberto | |
| Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss | 2025 | Pistolesi, Alessandra; Tuniz, Simone; Luceri, Cristina; Molli, Alice; Urru, Matteo; La Rocca, Antonino Iurato; Tanturli, Michele; De Cesaris, Francesco; Buonvicino, Daniela; Chiarugi, Alberto | |
| Chronic headaches and medication overuse | 2010 | Geppetti P.; De Cesaris F.; Nicoletti P.; Benemei S. | |
| COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report | 2021 | Iannone L.F.; Geppetti P.; Chiarugi A.; De Cesaris F. | |
| Criterion-related validity in a sample of migraine outpatients: The diagnostic criteria for psychosomatic research | 2020 | Cosci F.; Svicher A.; Romanazzo S.; Maggini L.; De Cesaris F.; Benemei S.; Geppetti P. | |
| Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine | 2022 | Iannone, Luigi Francesco; De Cesaris, Francesco; Ferrari, Anita; Benemei, Silvia; Fattori, Davide; Chiarugi, Alberto | |
| Emerging Pharmacological Treatments for Migraine in the Pediatric Population | 2022 | Iannone L.F.; De Cesaris F.; Geppetti P. | |
| Epidemiology and determinants of chronic migraine: A real-world cohort study, with nested case-control analysis, in primary care in Italy | 2019 | Marconi E.; Pecchioli S.; Nica M.; Colombo D.; Mazzoleni F.; De Cesaris F.; Geppetti P.; Cricelli C.; Lapi F. | |
| Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series | 2022 | Iannone L.F.; Fattori D.; Geppetti P.; De Cesaris F. | |
| Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe) | 2020 | Delussi M.; Gentile E.; Coppola G.; Prudenzano A.M.P.; Rainero I.; Sances G.; Abagnale C.; Caponnetto V.; De Cesaris F.; Frattale I.; Guaschino E.; Marcinno A.; Ornello R.; Pistoia F.; Putorti A.; Roca M.E.; Roveta F.; Lupi C.; Trojano M.; Pierelli F.; Geppetti P.; Sacco S.; de Tommaso M. | |
| Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score | 2022 | Iannone L.F.; Fattori D.; Benemei S.; Chiarugi A.; Geppetti P.; De Cesaris F. | |
| Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study | 2020 | Benemei S.; Lupi C.; De Cesaris F.; Lombardi N.; Bettiol A.; Chiarugi A.; Geppetti P.; Galli V.; Pracucci C.; Occupati B.; Mannaioni G. | |
| Mental pain and pain-proneness in migraine subjects: Results from the PAINMIG cohort-study | 2021 | Cosci F.; Svicher A.; Mansueto G.; Benemei S.; Chiarugi A.; De Cesaris F.; Guidi J.; Zipfel S. | |
| Mental pain as a global person-centred outcome measure | 2021 | Cosci F.; Mansueto G.; Benemei S.; Chiarugi A.; De Cesaris F.; Sensky T. | |
| Mental Pain Questionnaire: An item response theory analysis | 2019 | Svicher, A.; Romanazzo, S.; De Cesaris, F.; Benemei, S.; Geppetti, P.; Cosci, F. | |
| Mental Pain Questionnaire: Clinimetric Properties of a Potential Global Person‐Centred Outcome Measure | 2024 | Cosci Fiammetta; Carrozzino Danilo; Patierno Chiara; Romanazzo Sara; Berrocal Carmen; Chiarugi Alberto; De Cesaris Francesco; Guiducci Serena; Mansueto Giovanni; Christensen KajSparle; Sensky Tom | |
| Migraine during covid-19: Data from second wave pandemic in an Italian cohort | 2021 | Gentile E.; Delussi M.; Abagnale C.; Caponnetto V.; De Cesaris F.; Frattale I.; Guaschino E.; Marcinno A.; Ornello R.; Pistoia F.; Putorti A.; Candida G.; Roveta F.; Lupi C.; Coppola G.; Prudenzano A.M.P.; Rainero I.; Sances G.; Roca M.E.; Trojano M.; Pierelli F.; Geppetti P.; Sacco S.; de Tommaso M. | |
| Migraine Models | 2009 | S. Benemei; F. De Cesaris; P. Nicoletti; S. Materazzi; R. Nassini; P. Geppetti. | |
| Migraine-provoking substances evoke periorbital allodynia in mice | 2019 | De Logu F.; Landini L.; Janal M.N.; Li Puma S.; De Cesaris F.; Geppetti P.; Nassini R. | |
| Multi-domain destructuring in the early phases of psychosis: a multicentric phenomenological and psychometric case-control study | 2025 | Baccaredda Boy O, Merola GP, Patti A, Bozza B, Flaccomio D, Faldi M, Pitt G, Papini L, Pecoraro V, Noschese I, Di Matteo E, Brugnolo D, Ricci C, Ballerini A, Mauceri F, Tavano S, Peroni G, Ciabattini S, Gori S, Pisano T, De Cesaris F, Cohen D, Ricca V |